Skip to main content
. 2016 Nov 8;10:3673–3679. doi: 10.2147/DDDT.S100062

Figure 3.

Figure 3

PFS in younger and older patients receiving bortezomib and MP/VAD.

Abbreviations: PFS, progression-free survival; MP, melphalan-prednisolone; VAD, vincristine-adriamycin-dexamethasone.